Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Mouse models of tumor development in neurofibromatosis type 1.

Science (New York, N.Y.) | Dec 10, 1999

http://www.ncbi.nlm.nih.gov/pubmed/10591652

Neurofibromatosis type 1 (NF1) is a prevalent familial cancer syndrome resulting from germ line mutations in the NF1 tumor suppressor gene. Hallmark features of the disease are the development of benign peripheral nerve sheath tumors (neurofibromas), which can progress to malignancy. Unlike humans, mice that are heterozygous for a mutation in Nf1 do not develop neurofibromas. However, as described here, chimeric mice composed in part of Nf1-/- cells do, which demonstrates that loss of the wild-type Nf1 allele is rate-limiting in tumor formation. In addition, mice that carry linked germ line mutations in Nf1 and p53 develop malignant peripheral nerve sheath tumors (MPNSTs), which supports a cooperative and causal role for p53 mutations in MPNST development. These two mouse models provide the means to address fundamental aspects of disease development and to test therapeutic strategies.

Pubmed ID: 10591652 RIS Download

Mesh terms: Animals | Cell Line | Chimera | Disease Models, Animal | Female | Genes, Neurofibromatosis 1 | Genes, p53 | Germ-Line Mutation | Humans | Loss of Heterozygosity | Male | Mice | Mice, Inbred C57BL | Mice, Transgenic | Mutation | Nerve Sheath Neoplasms | Nerve Tissue Proteins | Neurofibromatosis 1 | Neurofibromin 1 | Proteins | S100 Proteins | Schwann Cells | Stem Cells

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

None

Mouse Genome Informatics (Data, Gene Annotation)

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.